A new tool for assessing hepatitis B treatment eligibility in Africa

Lancet Gastroenterol Hepatol. 2024 Apr;9(4):277-278. doi: 10.1016/S2468-1253(24)00006-2. Epub 2024 Feb 15.

Authors

Serge Ouoba¹, Moussa Lingani²

Affiliations

¹ Unité de Recherche Clinique de Nanoro, Institut de Recherche en Sciences de la Santé, Nanoro BP 18, Burkina Faso. Electronic address: sergeouoba@gmail.com.
² Unité de Recherche Clinique de Nanoro, Institut de Recherche en Sciences de la Santé, Nanoro BP 18, Burkina Faso.

PMID: 38367630
DOI: 10.1016/S2468-1253(24)00006-2

No abstract available

MeSH terms

Africa / epidemiology
Hepatitis B* / diagnosis
Hepatitis B* / drug therapy
Hepatitis B* / epidemiology
Hepatitis B, Chronic* / diagnosis
Hepatitis B, Chronic* / drug therapy
Hepatitis B, Chronic* / epidemiology
Humans